COSMOS Pharmaceutical Corporation
CSMYF · OTC
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Market Cap | $4 | $524 | $550 | $466 |
| - Cash | $0 | $57 | $23 | $39 |
| + Debt | $0 | $50 | $29 | $26 |
| Enterprise Value | $4 | $517 | $556 | $453 |
| Revenue | $2 | $259 | $246 | $244 |
| % Growth | -99.3% | 5.2% | 0.9% | – |
| Gross Profit | $0 | $54 | $53 | $52 |
| % Margin | 21% | 20.9% | 21.6% | 21.1% |
| EBITDA | $0 | $15 | $16 | $14 |
| % Margin | 6.6% | 5.9% | 6.5% | 5.8% |
| Net Income | $0 | $9 | $8 | $6 |
| % Margin | 3% | 3.3% | 3.2% | 2.6% |
| EPS Diluted | 0.7 | 108.95 | 99.86 | 79.3 |
| % Growth | -99.4% | 9.1% | 25.9% | – |
| Operating Cash Flow | – | $0 | $0 | $0 |
| Capital Expenditures | – | $0 | $0 | $0 |
| Free Cash Flow | – | $0 | $0 | $0 |